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A mong orally administered drugs,  tablets are the most popular because they are easier to handle 
and more portable than syrups and capsules [1].  
However,  difficulty in swallowing drugs is observed in 
10-40% of healthy subjects and in a greater percentage 
of elderly people with dysphagia,  leading to a reduction 
in adherence to medications [2].
Tablet size affects the ease of picking up and swal-
lowing of the tablets [1].  When the tablet is too small,  it 
is difficult to pick up,  and when it is too large,  it is dif-
ficult to swallow [1].  Oshima et al.  compared the ease 
of picking up and swallowing placebo tablets between 
132 healthy elderly people and 102 healthy university 
students by unaided visual observation of the tablets [3].  
They concluded that tablets ≤ 8 mm in diameter are easy 
to swallow,  and tablet sizes ≥ 7 mm are easy to pick up 
[3].  Kurata et al.  performed a subjective sensory evalu-
ation of the difficulty of picking up and swallowing an 
orally disintegrating placebo tablet in 84 people aged 
≥ 65 years [1].  They found that 76% of the participants 
had difficulty in swallowing a tablet with a diameter of 
15 mm.  They also found that a 13 mm diameter tablet 
is easier to pick up than an 8 mm diameter tablet [1].  
Schiele et al.  conducted a questionnaire survey of 11 
general practitioners and 1,051 patients taking medica-
tion [4].  They reported that 37.4% of the patients com-
plained of difficulty when taking the drug,  and that 
70.4% of the attending physicians were not aware of 
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Tablet size and head posture have been reported to affect swallowing of medications,  but no previous studies 
have evaluated their effects in detail.  Our aim was to investigate for the first time the effect of tablet size and 
head posture on drug swallowing by endoscopic evaluation in healthy subjects.  Round tablets (7 , 10 , 12,  and 
14 mm in diameter) were swallowed by 15 healthy adults with an endoscope inserted in the neutral,  head flex-
ion,  and head extension positions.  Evaluation of swallowing difficulty using a numeric rating scale (NRS),  
presence or absence of pharyngeal residue and its location,  and tablet oral transit time (TOTT) were recorded.  
In the neutral position,  the NRS score was higher with the 14 mm tablets than with the 7 mm tablets.  The 
TOTT with the 7 mm tablets was significantly shorter in the head extension than in the neutral position.  
Swallowing difficulty increased when the tablet diameter was more than 7 mm.  Residues were found in the epi-
glottis,  pyriform sinus,  and tongue base.  These findings suggest that head extension shortens the TOTT and 
assists oral-pharyngeal transport.
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such difficulty.  Difficulty in swallowing was reported 
with round tablets with an average diameter of 
8.7 ± 2.0 mm,  whereas no difficulty was reported with 
tablets with an average size of 8.1 ± 1.7 mm [4].  The 
evaluations in these studies were based on participants’ 
impressions when looking at the tablet and their subjec-
tive impressions after swallowing.  No studies have 
objectively evaluated tablet swallowing using video-en-
doscopy (VE) or video-fluorography (VF) in healthy 
subjects.  In addition,  no studies have objectively eval-
uated swallowing function when tablets are taken with 
different head postures [2 , 4 , 5].  The purpose of this 
study was to investigate the effects of tablet size and 
head posture on drug swallowing using subjective and 
objective evaluation methods in healthy subjects.
Materials and Methods
This study was conducted in accordance with the 
Declaration of Helsinki.  This study was approved by the 
Kanagawa Dental University Research Ethics Review 
Committee (approval number: 585) and registered in 
the UMIN Clinical Trial Registration (number: UMIN 
ID R000044760; registered February 17,  2020).  We 
explained the study procedures and ethical matters to 
the participants,  and written informed consent was 
obtained from all participants.
Determination of water volume when taking medi-
cations. Six participants swallowed a commercially 
available placebo tablet with a diameter of 7 mm 
(Placeplus®; Placebo Pharmaceutical,  Shiga,  Japan).  
Participants swallowed a total of 5 tablets using a total 
of 5 volumes of water in randomized order: 5 mL,  
10 mL,  15 mL,  20 mL,  or 30 mL.  The difficulty of 
swallowing the tablet in each trial was recorded by 
visual analog scale (VAS) as a subjective evaluation.  The 
suitable water volume for taking tablets was set based on 
the ease of taking tablets; the head was in a neutral 
position for this series of trials.
Preparation of tablets to be taken. The tablets 
used were prepared according to the pharmacist 
instructions.  A hot hand press analog HHT-1® (AS 
ONE,  Osaka,  Japan) was used to produce tablets with 
different diameters.  The composition was 99.0% crys-
talline cellulose and 1.0% sodium stearate.  Table 1 
shows the diameter,  thickness,  and weight of each tablet.
Participants and measurements. The study 
included 15 healthy adults with no clinical dysphagia.  
The participants’ age,  sex,  height,  and usual head pos-
ture (neutral,  head flexion,  or head extension) while 
taking medications were recorded.  Four types of tablets 
(A , B , C,  and D) with different diameters were admin-
istered to the participants in each of the three positions 
(12 trials for each participant).  The neutral,  head flex-
ion,  and head extension positions were determined 
using Mizuno’s method [6].  The head angle was 60° in 
the head flexion position,  90° in the neutral position,  
and 120° in the head extension position with reference 
to the Frankfurt plane,  which is the line connecting the 
external ear canal and the acromion when sitting 
(Fig. 1).  The participant sat in a wheelchair 
(KAJ202SB-42; Kawamura Cycle,  Hyogo,  Japan) with 
feet on the floor,  the head supported with a wheelchair 
pillow (Kurumaisuyou-antoudai; Nihon ISK,  Ibaraki,  
Japan),  and a cushion to maintain the neck angle 
during swallowing.  The plain water used for swallow-
ing tablets was colored with green dye (Shokuyou-
Shikiso: green; Kyouritsu Shokuhin,  Tokyo) so it 
could be observed with an endoscope.  A predeter-
mined amount of the colored water was placed into a 
catheter-tip type syringe (Terumo Syringe®,  50 mL,  
catheter-tip type; Terumo Corporation,  Tokyo) and an 
assistant directly injected it into the oral cavity while 
maintaining the swallowing position.  The subject was 
instructed to swallow immediately after the tablet was 
put into the oral cavity.  Before the measurement,  the 
participants took placebos (Placeplus®) in both the head 








Fig.  1　 Head position when swallowing tablets.  A,  Neutral 
position; B,  Head flexion position; C,  Head extension position.
Table 1　 Tablet characteristics
type diameter (mm) thickness (mm) weight (mg)
A  7 4 180
B 10 4 350
C 12 4 450
D 14 4 600
flexion and head extension positions for training.
A laryngoscope (ENT-30PC,  3.2 mm diame-
ter; Machida Seisakusho,  Chiba,  Japan) was used for 
the swallowing test and was inserted nasally after apply-
ing a lubricant (K-Y jelly; Reckitt Benckiser,  Slough,  
England) to the shaft of the endoscope.  VE images were 
obtained using a light source (RLED30; Machida 
Seisakusho),  monitor (LCD-GC252SXB; I-O Data 
Device,  Ishikawa,  Japan),  and video recording system 
(CA22WP; Machida Seisakusho).  After inserting the 
endoscope,  participants swallowed only the determined 
amount of water in the neutral position as a control 
during the first procedure.  In the second procedure,  
participants took a tablet of each diameter in a neutral 
head position with an amount of plain water deter-
mined by randomized order (4 times in total).  The 
same trials were then performed in the head flexion and 
head extension positions.  For each participant,  the 
order of the four differently sized tablets (tablets A to D) 
was randomized by a computer.  The subject and the 
monitor showing VE images were recorded simultane-
ously by a video camera (GZ-RY980; JVC Kenwood,  
Kanagawa,  Japan).
The subjective estimation of swallowing difficulty 
was expressed using the numeric rating scale (NRS) [7].  
In addition,  the occurrence of gag reflex and residue in 
the oral cavity were recorded.  After the examination,  
the recorded VE image was investigated,  and the tablet 
oral transit time (TOTT) (starting when the tablet 
entered the oral cavity,  to when swallowing occurred,  
then whiteout at the point of maximal pharyngeal con-
traction) was measured.  The occurrence of cough reflex 
during swallowing,  presence or absence of residue in 
the pharynx,  and location of residue were recorded.  
Statistical analysis. The results are shown as the 
median (interquartile range).  The Friedman test was 
used for the comparison of tablet diameter by NRS and 
TOTT in each posture and the comparison of the pos-
ture by NRS and TOTT for each tablet diameter.  The 
Mann-Whitney U Test and Kruskal-Wallis test were 
used for comparison of three or more groups,  and the 
Bonferroni test was performed in a post-hoc analysis.  
Cochran’s Q test was used to compare the occurrence of 
pharyngeal residue to the difference in tablet diameter 
in each posture,  and to compare the location of the res-
idue in the pharynx to the difference in posture for each 
tablet diameter,  and the Bonferroni test was used in a 
post-hoc analysis.  SPSS Statistics 26 (IBM Japan,  Tokyo,  
Japan) was used for statistical analysis.
Based on a previous study,  the required number of 
cases for 80% power was calculated to be 13,  consider-
ing an α error of 5% and a β error of 20% [8].  G*Power 
3.1 (Kiel University,  Kiel,  Germany) was used for cal-
culating sample size.  Assuming a dropout rate of 20%,  
15 patients were finally considered as the required 
number of cases.
Results
Background of subjects. The study included 15 
healthy adults (11 men and 4 women) with a median 
(interquartile range) age of 32 (29-35) years and a 
height of 168 (163-171) cm.  The usual head posture 
while taking tablets was the extended position in 11 
participants (73.3%) and the neutral position in 4 par-
ticipants (26.7%).
Determination of water intake when taking medi-
cation. Table 2 shows the VAS scores reflecting the 
ease of taking the placebo for each tested amount of 
drinking water.  A VAS value of 50 is considered the 
middle score,  at which a placebo tablet (diameter of 
7 mm) can be taken normally.  The median VAS value 
of 15 mL water was 49.5,  and that of 20 mL was 15.5,  
indicating a reduction in VAS with increasing water 
volume.  Based on the above results,  15 mL was consid-
ered the appropriate amount of water when taking tab-
lets in this study.
Performance status. In 180 trials,  NRS and 
TOTT were measurable in all tests.  The pharyngeal 
residue in 2 cases could not be confirmed after swallow-
ing due to cough reflex (tablet diameters of 10 mm and 
12 mm in the head extension position).  In 5 cases,  a 
tablet could not be delivered to the pharynx and 
remained in the oral cavity.  In addition,  in 3 cases,  the 
tablet returned to the oral cavity after being transferred 
to the pharynx.
NRS. Figures 2 and 3 show the NRS results for 
tablet swallowing.  The median NRS score for swallow-
ing 15 mL of water alone was 1 (0-3).  In all treatments,  
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Table 2　 VAS in determining water intake
5 mL 10 mL 15 mL 20 mL 30 mL
Max 100 80 70 52 35
Min  79  5  8  6  0
Median 93.5 67 49.5 15.5 17
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Fig.  2　 Comparison of NRS between tablet diameters.  Box and whisker plots of the NRS for each of four tablet diameters: 7 mm,  
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Fig.  3　 Comparison of NRS between postures.  Box and whisker plots of the NRS for each of three postures: the neutral position,  head 
flexion position and head extension position.
the NRS score was significantly different among the 4 
groups of tablet diameters (p = 0.047),  and multiple 
comparisons showed significantly different NRS scores 
between 7 mm and 14 mm (overall) (p = 0.030) (Fig. 2).  
In the neutral position,  a significant difference in NRS 
scores was found between the four groups (p = 0.0067).  
In multiple comparisons,  a significant difference in NRS 
scores was found between 7 mm and 14 mm in the neu-
tral position (p = 0.035),  but no difference was observed 
in the other postures (Fig. 2).  Comparison of NRS 
scores among postures showed no significant difference 
for each tablet diameter (Fig. 3).
TOTT. The TOTT results when swallowing tab-
lets are shown in Figures 4 and 5.  No significant differ-
ence was observed in the comparison of TOTT among 
tablet diameters in each posture (Fig. 4).  The compari-
son between the postures at each tablet diameter 
showed a significant difference in TOTT among the 
three groups (p = 0.032).  Multiple comparisons showed 
a significant difference in TOTT between the neutral 
and head extension positions with 7 mm tablets 
(p = 0.032) (Fig. 5).
Pharyngeal residue. Table 3 shows the findings 
in regard to residue within the pharynx.  Pharyngeal 
residual tablet was observed in 23 of 180 cases (12.8%).  
No significant difference was found between the tablet 
diameter and head posture with regard to the occur-
rence of residue in the pharynx.  Based on the VE 
images,  the pharyngeal residue was located in the epi-
glottic vallecula (VAL),  pyriform sinus (PS),  and 
tongue base (TB) (Fig. 6).  Residues were observed in 14 
cases (7.8%) in the VAL,  7 cases (3.9%) in the PS,  and 
2 cases (0.1%) in the TB.  Residues in the VAL were 
observed in all postures,  but residues in the PS were not 
found in the neutral position.  The median NRS score 
(interquartile range) was significantly higher when pha-
ryngeal residue was present than when pharyngeal resi-
due was absent,  i.e.,  7 (5-9) vs.  4 (2-7),  respectively 
(p = 0.00004).
Discussion
This study showed that the NRS score increased in 
proportion to an increase in tablet diameter.  In partic-
ular,  a tablet with 14 mm diameter was more difficult to 
swallow than a tablet with 7 mm diameter in the neutral 
position.  TOTT was significantly shortened in the head 
extension position when a tablet of 7 mm diameter was 
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Fig.  4　 Comparison of TOTT between tablet diameters.  Box and whisker plots of the TOTT for each of four tablet diameters: 7 mm,  
10 mm,  12 mm and 14 mm.
swallowed.  Residues in the pharynx were observed in 
the VAL,  PS,  and TB.
Two patient studies have reported the objective eval-
uation of tablet swallowing using VE examination.  
Mann and Crary evaluated the swallowing of normal 
and orally disintegrating tablets (ODTs) in 36 patients 
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Table 3　 Pharyngeal residue
7 mm 10 mm 12 mm 14 mm total
Pharyngeal residue
Neutral 3 1 2 2 8
Head flexion 2 2 1 3 8
Head extension 1 3 2 1 7
Total 6 6 5 6 23
Vallecula
Neutral 3 1 2 2 8
Head flexion 1 1 0 0 2
Head extension 1 1 1 1 4
Total 5 3 3 3 14
Pyriform sinus 
Neutral 0 0 0 0 0
Head flexion 1 1 1 2 5
Head extension 0 2 0 0 2
Total 1 3 1 2 7
Tongue base
Neutral 0 0 0 0 0
Head flexion 0 0 0 1 1
Head extension 0 0 1 0 1






































































Fig.  5　 Comparison of TOTT between postures.  Box and whisker plots of the TOTT for each of three postures: the neutral position,  
head flexion position and head extension position.
with dysphagia [9].  When swallowing a normal tablet as 
compared to an ODT,  significantly greater surface elec-
tromyographic amplitude and longer total swallowing 
time were observed.  Buhmann et al.  evaluated swallow-
ing function by swallowing endoscopy in 118 patients 
with Parkinson’s disease (PD) and 32 healthy subjects 
[10].  They found that 28% of PD patients and 16% of 
controls showed substantial impairment in the ability to 
swallow medication.  However,  problems in the study 
included tablets dissolving in the pharynx or oral cavity,  
coughing,  and the need to drink water repeatedly after 
swallowing the tablets.
The evaluation measures of our study were the NRS 
score after swallowing as a subjective evaluation,  TOTT 
as an objective evaluation,  and pharyngeal residue.  The 
NRS can capture detailed subjective changes.  It is useful 
to convey subjective numerical evaluation results in a 
short time after swallowing,  when the endoscope is 
inserted nasally.  Total time to swallow (TTS),  mea-
sured as the time from when an oropharyngeal tablet is 
placed on the tongue until the time it disappears,  has 
previously been used as an objective evaluation of the 
tablet swallowing time [9].  TTS captures the total time 
of swallowing — including the preparation,  oral,  and 
pharyngeal stages — as well as the additional swallow-
ing period when the tablet remains in the pharynx [9].  
In this case,  the presence or absence of residue in the 
pharynx greatly affects the results,  masking the differ-
ences in time between the 5 swallowing stages.  Similar 
to TTS,  TOTT starts when the tablet is placed in the 
oral cavity,  but unlike in TTS,  TOTT ends when 
whiteout is observed with the endoscope.  Whiteout 
with VE is a phenomenon that occurs when the soft 
palate or the base of the tongue is elevated approxi-
mately 0.02 sec after the swallowing reflex is triggered 
[11].  Therefore,  whiteout could be used as a standard 
point when the pharyngeal swallowing reflex begins.  In 
other words,  TOTT is an index that is not affected by 
the time change due to residue in the oral cavity and 
pharynx after the swallowing reflex.  TOTT reflects the 
temporal effects on the movement of tablets in the oral 
cavity and the movement from the oral cavity to the 
pharynx due to changes in tablet diameter and posture 
during swallowing.
A previous study reported that a tablet diameter of 
7 mm or more is “easy to pinch” and is desirable [3].  On 
the other hand,  in the same study about 70% of healthy 
elderly people found it difficult to swallow a 10 mm 
tablet,  suggesting that swallowing becomes difficult 
when the tablet is large [3].  In this study,  we included 
healthy adults and allowed them to swallow tablets of 
diameter 7 mm,  10 mm,  12 mm,  and 14 mm.  The 
NRS score tended to gradually increase as the tablet 
diameter increased,  and a significant difference was 
observed between 7 mm and 14 mm in the neutral head 
position of swallowing (Fig. 2).  The difficulty in swal-
lowing increased as the tablet diameter increased,  
which is the same result as in the previous report [3].
  On the other hand,  no significant difference was 
found in TOTT or the frequency of pharyngeal residue,  
as the present study included young adults who had a 
swallowing function tolerance (“reserve”).  Hence,  tab-
let diameter may not have affected these factors [12].  In 
other words,  young adults have more than the mini-
mum necessary swallowing function; therefore,  they 
can cope with inadequate bolus formation during the 
preparatory stage.  In addition,  young adults have lon-
ger hyoid bones,  greater laryngeal elevation,  and a 
larger amount of movement than the elderly [12].  On 
the other hand,  there is little “reserve” in the elder-
ly; therefore,  if the study was conducted in the same 
settings for the elderly,  a significant difference in TOTT 
and pharyngeal residue may have been observed.
With regard to the relationship between posture and 
NRS,  a significant difference was found between the 
tablet diameters of 7 mm and 14 mm in the neutral 
head position,  but no significant difference was noted in 
NRS according to tablet diameter in the head flexion 
and head extension positions (Fig. 2).  However,  when 
the tablet diameters were 7,  10,  and 12 mm,  the 
median NRS was 3 in the neutral head position and 4 to 
5 in the head flexion and extension positions,  thus sug-
gesting that the head flexion and extension positions 
might have been set at different angles from the usual 







Fig.  6　 Location of pharyngeal residual tablet.  Endoscopic 
images of the pharynx immediately after tablet swallowing.  The 
white arrow indicates the position of the residual tablet.
head postures during tablet intake for each subject.
The results showed that the TOTT in the head 
extension position was significantly shorter than that in 
the neutral head position when swallowing a 7 mm tab-
let.  Forough et al.  stated that when a person who has no 
dysphagia complains of difficulty in swallowing when 
taking medication,  it is best to start with posture 
adjustment,  which  does not require invasive or special 
preparation [2].  Kaplan et al.  compared the medica-
tion-swallowing status in the neutral,  chin-up,  chin 
down,  and lateral rotation positions and stated that the 
neutral and chin down positions are the preferred pos-
tures for taking drugs [5].  Schiele et al.  introduced the 
pop-bottle method with head extension movement and 
lean-forward with head flexion movement when taking 
drugs [13].  Calvo et al.  used the chin-up posture as a 
compensatory procedure in patients with oral disorders 
but no laryngo-pharyngeal disorders,  such as those 
with postoperative tongue cancer and cerebrovascular 
disorders with motor paralysis confined to the hypo-
glossal nerve [14].  In this method,  gravity assists the 
feeding movement from the oral cavity to the pharynx,  
which is normally performed by tongue movement 
[14].
When we investigated the usual head posture for 
taking tablets,  73.3% of participants used the neutral 
position,  26.7% used the head extension position,  and 
none used the head flexion position.  The head exten-
sion compensation method was performed for tablet 
swallowing in approximately 25% of healthy subjects.  It 
can be inferred that it is more difficult to transport the 
tablet from the oral cavity to the pharynx than the food 
bolus; thus,  the compensatory method is convention-
ally performed.  This result shows that TOTT was 
shorter in the head extension than in the neutral head 
position when swallowing a 7 mm tablet,  which is con-
sidered to be the result of gravity-assisted oropharyn-
geal transport.  The advantage of head extension was 
limited to tablets of 7 mm diameter or less,  because the 
difference in posture showed no effect while swallowing 
tablets with a diameter of 10 mm or more.  In addition,  
the head extension swallowing method is not recom-
mended for patients with pharyngeal dysphagia because 
it requires sufficient swallowing function tolerance 
(“reserve”) [12].
In this endoscopic evaluation,  we found variations 
in the location of pharyngeal residual tablet,  such as the 
VAL,  PS,  and TB.  A previous study using VE for 
patients with PD has shown that tablets become stuck in 
the epiglottis or that disintegrated tablets remain [8].  
Our present study is the first to show by means of endo-
scopic images that residual tablet remained in the PS 
and TB after swallowing (Fig. 6).  Previously,  the PS and 
VAL have been reported as the sites of frequent pharyn-
geal food residue [12].  The mechanism differs depend-
ing on the location of residue.  VAL residue increases 
when epiglottic anatomical morphology and/or epiglot-
tic inversion is weakened due to reduced hyoid eleva-
tion [15].  PS residue is said to be caused by a decrease 
in pharyngeal contraction force or a decrease in the 
amount of upper esophageal opening [15].  TB residue 
increases when the propulsive force of the tongue weak-
ens [15].  In the present study,  although we found no 
significant difference between the frequency of PS resi-
due and that of TB residue,  there was little residue on 
the VAL in the head flexion position.  It has been 
reported that in head flexion,  the distance between the 
epiglottis and the TB is shortened and the space in the 
VAL is narrowed,  so that the VAL residue is likely 
reduced [16].  On the other hand,  in our series there 
were many residues in the PS in the head extension 
position and no residue on the PS in the neutral head 
position.  Residue in the PS may increase because the 
epiglottic pressure increases,  but the hypopharyngeal 
contraction pressure decreases in the chin tuck position 
[17].  In addition,  both head flexion and extension 
positions shorten the opening time of the upper esoph-
ageal sphincter [18].  The neutral head position may 
result in good clearance of the PS.  Although the loca-
tion of the pharyngeal residual tablet changed with the 
change in swallowing posture,  the frequency of occur-
rence of pharyngeal residue did not change.  It is tradi-
tionally considered that posture adjustment is useful for 
assisting swallowing function [19],  but changing the 
swallowing posture is not always effective to avoid pha-
ryngeal residual tablet.
The limitations of the present study are as follows.  
First,  in order to investigate the effect of tablet diameter 
on swallowing function,  a cylindrical tablet was made 
with a tableting machine,  but many tablets on the mar-
ket are shaped as ordinary R and two-stage R tablets 
without corners [20].  The corners may cause more fric-
tion with the oropharyngeal mucosa than the regular 
tablets.  Buhmann et al.  examined the effect of tablet 
coating and reported that a coated tablet is easier to 
swallow than a non-coated tablet even if it is large [10].  
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Thus the reduction of friction by tablet coating may 
greatly affect the ease of swallowing.  However,  the 
effect of tablet shape on swallowing function is still 
unknown.
Secondly,  we performed a video-endoscopic swal-
lowing study as an objective evaluation of swallowing 
function,  but the presence of the endoscope inserted 
through the nose promotes discomfort during swallow-
ing and may affect the NRS.  The median (interquartile 
range) NRS score when swallowing 15 mL of water after 
endoscopic insertion was 1 (0-3); thus,  the NRS result 
during tablet swallowing should be adjusted by sub-
tracting the discomfort from endoscopic insertion.  In 
addition,  fixation of the head using a wheelchair pillow 
might have caused tension in the neck during swallow-
ing,  which could have affected the NRS.  
Finally,  although the water amount required for 
tablet swallowing was determined with the head in the 
neutral position,  the appropriate water amount may 
differ if the head is in the flexion or extension position.  
In future studies,  the appropriate amount of water 
should be confirmed even in head flexion and extension 
in order to improve the validity of the study.
In conclusion,  when the tablet diameter was 
increased to more than 7 mm,  our participants found 
the tablet difficult to swallow,  and the head extension 
position shortened the tablet oral transit time and 
assisted the oral-pharyngeal transfer of the tablet.  
Based on the above results,  it will be most convenient 
for a person without dysphagia to swallow a 7 mm 
diameter tablet in a head extension position.  However,  
depending on the patient’s posture,  the tablets may 
remain not only in the VAL but also in the PS and TB.  
In the elderly and in patients with dysphagia,  depend-
ing on the type of impaired swallowing,  adjusting the 
tablet mold may be considered necessary.
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